(Q35798580)

10 August 2017

Establishment of patient-derived cancer xenografts in immunodeficient NOG mice (English)

1 reference

10 August 2017

1 reference

Tsuyoshi Chijiwa

1

1 reference

10 August 2017

Kenji Kawai

2

1 reference

10 August 2017

Akira Noguchi

3

1 reference

10 August 2017

Hidemitsu Sato

4

1 reference

10 August 2017

Akimune Hayashi

5

1 reference

10 August 2017

Haruhiko Cho

6

1 reference

10 August 2017

Manabu Shiozawa

7

1 reference

10 August 2017

Takeshi Kishida

8

1 reference

10 August 2017

Soichiro Morinaga

9

1 reference

10 August 2017

Tomoyuki Yokose

10

1 reference

10 August 2017

Makoto Katayama

11

1 reference

10 August 2017

Nobuo Takenaka

12

1 reference

10 August 2017

Hiroshi Suemizu

13

1 reference

10 August 2017

Roppei Yamada

14

1 reference

10 August 2017

Yoshiyasu Nakamura

15

1 reference

10 August 2017

Takashi Ohtsu

16

1 reference

10 August 2017

Yasuo Takano

17

1 reference

10 August 2017

Kohzoh Imai

18

1 reference

10 August 2017

Yohei Miyagi

19

1 reference

10 August 2017

Masato Nakamura

20

1 reference

10 August 2017

11 May 2015

1 reference

International Journal of Oncology

10 August 2017

1 reference

10 August 2017

47

1 reference

10 August 2017

61-70

1 reference

10 August 2017

1

1 reference

Characterization of EBV-related lymphoproliferative lesions arising in donor lymphocytes of transplanted human tumor tissues in the NOG mouse

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

Assessment of a novel VEGF targeted agent using patient-derived tumor tissue xenograft models of colon carcinoma with lymphatic and hepatic metastases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

Semi-quantitative analyses of metabolic systems of human colon cancer metastatic xenografts in livers of superimmunodeficient NOG mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

Thrombospondin 2 inhibits metastasis of human malignant melanoma through microenvironment-modification in NOD/SCID/gammaCnull (NOG) mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

A new model of patient tumor-derived breast cancer xenografts for preclinical assays

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

Establishment of human tumor xenografts in immunodeficient mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

Contributions of human tumor xenografts to anticancer drug development

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

Potential of the scid mouse as a host for human tumors

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

Small bud of probable gastrointestinal stromal tumor within a laparoscopically-resected gastric schwannoma.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouse.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

SCID mouse models to study human cancer pathogenesis and approaches to therapy: potential, limitations, and future directions

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4485657

Engraftment of human non-Hodgkin lymphomas in mice with severe combined immunodeficiency

15 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25963555

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Is xenotransplantability of human colon cancers in SCID mice affected by angiogenic factors?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25963555

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3892/IJO.2015.2997

1 reference

10 August 2017

1 reference

10 August 2017

1 reference